Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AER 001 in Atopic Asthma
NCT00535028Phase 2Completed
- Sponsor
- Aerovance
- Start
- Jan 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of pitrakinra in allergic asthma, sponsored by Aerovance. Started Jan 2005; status: completed.
02
Drugs
pitrakinra
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00535028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535028.